Annual SG&A:
$0.00-$1.34B(-100.00%)Summary
- As of today, JAZZ annual SG&A is $0.00, with the most recent change of -$1.34 billion (-100.00%) on December 31, 2024.
- During the last 3 years, JAZZ annual SG&A has fallen by -$1.45 billion (-100.00%).
- JAZZ annual SG&A is now -100.00% below its all-time high of $1.45 billion, reached on December 31, 2021.
Performance
JAZZ SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly SG&A:
$358.40M-$155.61M(-30.27%)Summary
- As of today, JAZZ quarterly SG&A is $358.40 million, with the most recent change of -$155.61 million (-30.27%) on June 30, 2025.
- Over the past year, JAZZ quarterly SG&A has increased by +$19.88 million (+5.87%).
- JAZZ quarterly SG&A is now -30.27% below its all-time high of $514.01 million, reached on March 31, 2025.
Performance
JAZZ Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM SG&A:
$3.29B-$679.87M(-17.13%)Summary
- As of today, JAZZ TTM SG&A is $3.29 billion, with the most recent change of -$679.87 million (-17.13%) on June 30, 2025.
- Over the past year, JAZZ TTM SG&A has increased by +$1.90 billion (+135.89%).
- JAZZ TTM SG&A is now -25.00% below its all-time high of $4.39 billion.
Performance
JAZZ TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Selling, General & Administrative Expenses Formula
SG&A = Total Operating Expenses - Cost of Goods Sold - Research & Development
JAZZ Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -100.0% | +5.9% | +135.9% |
| 3Y3 Years | -100.0% | -2.2% | +128.9% |
| 5Y5 Years | -100.0% | +87.3% | +300.5% |
JAZZ Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -100.0% | at low | -30.3% | +20.3% | -17.1% | +1.8% |
| 5Y | 5-Year | -100.0% | at low | -30.3% | +72.9% | -25.0% | +1.8% |
| All-Time | All-Time | -100.0% | at low | -30.3% | +2524.3% | -25.0% | +260.8% |
JAZZ Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $358.40M(-30.3%) | $1.57B(+1.3%) |
| Mar 2025 | - | $514.01M(+39.2%) | $1.55B(+11.7%) |
| Dec 2024 | $0.00(-100.0%) | $369.29M(+13.4%) | $1.39B(-1.9%) |
| Sep 2024 | - | $325.77M(-3.8%) | $1.41B(+1.3%) |
| Jun 2024 | - | $338.52M(-3.7%) | $1.39B(-0.2%) |
| Mar 2024 | - | $351.71M(-11.2%) | $1.40B(+4.0%) |
| Dec 2023 | $1.34B(-5.2%) | $396.03M(+28.5%) | $1.34B(+1.0%) |
| Sep 2023 | - | $308.31M(-9.5%) | $1.33B(-3.6%) |
| Jun 2023 | - | $340.84M(+14.4%) | $1.38B(-1.8%) |
| Mar 2023 | - | $297.92M(-22.3%) | $1.41B(-0.8%) |
| Dec 2022 | $1.42B(-2.4%) | $383.20M(+6.9%) | $1.42B(-1.1%) |
| Sep 2022 | - | $358.48M(-2.2%) | $1.43B(-0.4%) |
| Jun 2022 | - | $366.47M(+18.7%) | $1.44B(-4.2%) |
| Mar 2022 | - | $308.81M(-22.5%) | $1.50B(+3.3%) |
| Dec 2021 | $1.45B(+69.9%) | $398.46M(+9.6%) | $1.45B(+11.6%) |
| Sep 2021 | - | $363.68M(-15.2%) | $1.30B(+13.7%) |
| Jun 2021 | - | $429.03M(+64.7%) | $1.14B(+26.2%) |
| Mar 2021 | - | $260.51M(+5.4%) | $906.34M(+6.1%) |
| Dec 2020 | $854.23M(+15.9%) | $247.17M(+19.3%) | $854.23M(+4.0%) |
| Sep 2020 | - | $207.25M(+8.3%) | $821.34M(+3.6%) |
| Jun 2020 | - | $191.41M(-8.2%) | $792.79M(+2.0%) |
| Mar 2020 | - | $208.40M(-2.7%) | $777.39M(+5.5%) |
| Dec 2019 | $736.94M(+7.8%) | $214.28M(+19.9%) | $736.94M(+7.7%) |
| Sep 2019 | - | $178.71M(+1.5%) | $684.53M(+3.5%) |
| Jun 2019 | - | $176.01M(+4.8%) | $661.70M(+2.7%) |
| Mar 2019 | - | $167.95M(+3.8%) | $644.26M(-5.7%) |
| Dec 2018 | $683.53M(+25.6%) | $161.87M(+3.8%) | $683.53M(+2.8%) |
| Sep 2018 | - | $155.87M(-1.7%) | $664.72M(+4.9%) |
| Jun 2018 | - | $158.58M(-23.5%) | $633.37M(+4.3%) |
| Mar 2018 | - | $207.21M(+44.9%) | $607.11M(+11.6%) |
| Dec 2017 | $544.16M(+8.2%) | $143.05M(+14.9%) | $544.16M(+3.0%) |
| Sep 2017 | - | $124.52M(-5.9%) | $528.25M(+0.0%) |
| Jun 2017 | - | $132.33M(-8.3%) | $528.09M(+1.9%) |
| Mar 2017 | - | $144.25M(+13.5%) | $518.38M(+3.1%) |
| Dec 2016 | $502.89M(+12.0%) | $127.14M(+2.2%) | $502.89M(+0.3%) |
| Sep 2016 | - | $124.37M(+1.4%) | $501.31M(+4.2%) |
| Jun 2016 | - | $122.62M(-4.8%) | $480.98M(+3.3%) |
| Mar 2016 | - | $128.76M(+2.6%) | $465.50M(+3.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2015 | $449.12M(+10.6%) | $125.56M(+20.7%) | $449.12M(+4.6%) |
| Sep 2015 | - | $104.04M(-2.9%) | $429.26M(+2.5%) |
| Jun 2015 | - | $107.13M(-4.7%) | $418.71M(+1.6%) |
| Mar 2015 | - | $112.39M(+6.3%) | $412.14M(+1.5%) |
| Dec 2014 | $406.11M(+33.5%) | $105.69M(+13.0%) | $406.11M(+6.4%) |
| Sep 2014 | - | $93.50M(-7.0%) | $381.72M(+5.1%) |
| Jun 2014 | - | $100.56M(-5.5%) | $363.19M(+6.8%) |
| Mar 2014 | - | $106.36M(+30.8%) | $340.14M(+11.8%) |
| Dec 2013 | $304.30M(+35.9%) | $81.30M(+8.4%) | $304.30M(+7.0%) |
| Sep 2013 | - | $74.97M(-3.3%) | $284.38M(+5.2%) |
| Jun 2013 | - | $77.51M(+9.9%) | $270.33M(+6.7%) |
| Mar 2013 | - | $70.53M(+14.9%) | $253.47M(+10.2%) |
| Dec 2012 | $223.88M(+105.5%) | $61.38M(+0.7%) | $229.94M(+12.2%) |
| Sep 2012 | - | $60.92M(+0.5%) | $204.94M(+17.4%) |
| Jun 2012 | - | $60.64M(+29.0%) | $174.57M(+28.3%) |
| Mar 2012 | - | $47.00M(+29.2%) | $136.02M(+24.9%) |
| Dec 2011 | $108.94M(+57.9%) | $36.38M(+19.1%) | $108.94M(+21.6%) |
| Sep 2011 | - | $30.55M(+38.3%) | $89.62M(+16.2%) |
| Jun 2011 | - | $22.09M(+11.0%) | $77.11M(+6.9%) |
| Mar 2011 | - | $19.91M(+16.6%) | $72.12M(+4.5%) |
| Dec 2010 | $69.00M(+17.6%) | $17.07M(-5.4%) | $69.00M(+2.0%) |
| Sep 2010 | - | $18.04M(+5.5%) | $67.64M(+4.6%) |
| Jun 2010 | - | $17.10M(+1.8%) | $64.67M(+5.6%) |
| Mar 2010 | - | $16.79M(+6.8%) | $61.23M(+4.4%) |
| Dec 2009 | $58.65M(-47.4%) | $15.72M(+4.4%) | $58.65M(-7.1%) |
| Sep 2009 | - | $15.06M(+10.3%) | $63.12M(-12.8%) |
| Jun 2009 | - | $13.66M(-3.9%) | $72.39M(-22.0%) |
| Mar 2009 | - | $14.22M(-29.6%) | $92.84M(-16.7%) |
| Dec 2008 | $111.40M(+41.8%) | $20.18M(-17.0%) | $111.40M(-6.5%) |
| Sep 2008 | - | $24.33M(-28.7%) | $119.17M(+5.5%) |
| Jun 2008 | - | $34.11M(+4.1%) | $112.92M(+16.4%) |
| Mar 2008 | - | $32.78M(+17.3%) | $96.98M(+23.5%) |
| Dec 2007 | $78.54M(+52.8%) | $27.96M(+54.7%) | $78.54M(+55.3%) |
| Sep 2007 | - | $18.07M(-0.6%) | $50.58M(+55.6%) |
| Jun 2007 | - | $18.18M(+26.8%) | $32.51M(+126.8%) |
| Mar 2007 | - | $14.34M | $14.34M |
| Dec 2006 | $51.38M(+118.2%) | - | - |
| Dec 2005 | $23.55M(+215.7%) | - | - |
| Dec 2004 | $7.46M | - | - |
FAQ
- What is Jazz Pharmaceuticals plc annual SG&A?
- What is the all-time high annual SG&A for Jazz Pharmaceuticals plc?
- What is Jazz Pharmaceuticals plc annual SG&A year-on-year change?
- What is Jazz Pharmaceuticals plc quarterly SG&A?
- What is the all-time high quarterly SG&A for Jazz Pharmaceuticals plc?
- What is Jazz Pharmaceuticals plc quarterly SG&A year-on-year change?
- What is Jazz Pharmaceuticals plc TTM SG&A?
- What is the all-time high TTM SG&A for Jazz Pharmaceuticals plc?
- What is Jazz Pharmaceuticals plc TTM SG&A year-on-year change?
What is Jazz Pharmaceuticals plc annual SG&A?
The current annual SG&A of JAZZ is $0.00
What is the all-time high annual SG&A for Jazz Pharmaceuticals plc?
Jazz Pharmaceuticals plc all-time high annual SG&A is $1.45B
What is Jazz Pharmaceuticals plc annual SG&A year-on-year change?
Over the past year, JAZZ annual SG&A has changed by -$1.34B (-100.00%)
What is Jazz Pharmaceuticals plc quarterly SG&A?
The current quarterly SG&A of JAZZ is $358.40M
What is the all-time high quarterly SG&A for Jazz Pharmaceuticals plc?
Jazz Pharmaceuticals plc all-time high quarterly SG&A is $514.01M
What is Jazz Pharmaceuticals plc quarterly SG&A year-on-year change?
Over the past year, JAZZ quarterly SG&A has changed by +$19.88M (+5.87%)
What is Jazz Pharmaceuticals plc TTM SG&A?
The current TTM SG&A of JAZZ is $3.29B
What is the all-time high TTM SG&A for Jazz Pharmaceuticals plc?
Jazz Pharmaceuticals plc all-time high TTM SG&A is $4.39B
What is Jazz Pharmaceuticals plc TTM SG&A year-on-year change?
Over the past year, JAZZ TTM SG&A has changed by +$1.90B (+135.89%)